Literature DB >> 6180173

Effect of interferon on the replication of mink cell focus-inducing virus in murine cells: synthesis, processing, assembly, and release of viral proteins.

J A Bilello, N A Wivel, P M Pitha.   

Abstract

Treatment of mink cell focus-inducing (MCF) virus (isolate AK-13) producing SC-1 cells with mouse fibroblast interferon (150 to 600 U/ml) led to a 100-fold decrease in the release of infectious virus, whereas there was a 2.5- to 10-fold decrease in various parameters of virus particle release. Analysis of labeled virion proteins indicated that a temporal change in virion protein composition occurred after interferon treatment. After a 24-h exposure of chronically infected cells to interferon, the virions produced contained a 85,000-dalton glycoprotein (apparently of nonviral origin) which was in excess of the virus envelope glycoprotein gp70. Particles produced from cells treated with interferon for 32 to 48 h were nearly devoid of gp70 and contained substantially lower quantities of p30. Intracellular processing of viral precursor polyproteins to the mature virion structural proteins was not altered in the presence of interferon. However, an accumulation of the viral p30 and p12E proteins was observed in interferon-treated cells, consistent with an increase in cell-associated virions. Immunoprecipitation analysis of the tissue culture fluids from [35S]methionine-labeled control and interferon-treated cells revealed marked decrease in p30 and p15E/p12E released after interferon treatment. In contrast, gp70 did not accumulate in interferon-treated cells, but was released into the culture medium in a form that was neither pelletable nor associated with p15E/p12E.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6180173      PMCID: PMC256112     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Polypeptides of mammalian oncornaviruses. IV. Structural components of murine leukemia virus released as soluble antigens in cell culture.

Authors:  D P Bolognesi; A J Langlois; W Schäfer
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  Interferon inhibits mouse leukaemia virus release: an electron microscope study.

Authors:  E H Chang; S J Mims; T J Triche; R M Friedman
Journal:  J Gen Virol       Date:  1977-02       Impact factor: 3.891

3.  Trapping of oncornavirus particles at the surface of interferon-treated cells.

Authors:  A Billiau; H Heremans; P T Allen; J De Maeyer-Guignard; P De Somer
Journal:  Virology       Date:  1976-09       Impact factor: 3.616

4.  Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus.

Authors:  D H Metz; M Esteban
Journal:  Nature       Date:  1972-08-18       Impact factor: 49.962

5.  Inhibition of murine leukemia virus production in chronically infected AKR cells: a novel effect of interferon.

Authors:  R M Friedman; J M Ramseur
Journal:  Proc Natl Acad Sci U S A       Date:  1974-09       Impact factor: 11.205

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  The synthesis of poxvirus-specific RNA in interferon-treated cells.

Authors:  C Jungwirth; I Horak; G Bodo; J Lindner; B Schultze
Journal:  Virology       Date:  1972-04       Impact factor: 3.616

8.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

9.  Effect of interferon on exogenous, endogenous, and chroniv murine leukemia virus infection.

Authors:  P M Pitha; W P Rowe; M N Oxman
Journal:  Virology       Date:  1976-04       Impact factor: 3.616

10.  Interferon and murine leukemia. VI. Effect of interferon preparations on the lymphoid leukemia of AKR mice.

Authors:  I Gresser; J Coppey; C Bourali
Journal:  J Natl Cancer Inst       Date:  1969-11       Impact factor: 13.506

View more
  5 in total

1.  An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein.

Authors:  Stuart J D Neil; Virginie Sandrin; Wesley I Sundquist; Paul D Bieniasz
Journal:  Cell Host Microbe       Date:  2007-09-13       Impact factor: 21.023

2.  Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated alpha 2-interferon.

Authors:  D P Bednarik; J D Mosca; N B Raj; P M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon.

Authors:  M S Smith; R J Thresher; J S Pagano
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

4.  Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle.

Authors:  Y Shirazi; P M Pitha
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses.

Authors:  I Gorska-Flipot; M Huang; M Cantin; E Rassart; G Massé; P Jolicoeur
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.